FDA Announces Joint Meeting of Advisory Committees, Requests Public Comments

Summary

The Food and Drug Administration (FDA) is hosting a joint meeting of its Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee to provide advice on FDA's regulatory issues, with at least one portion closed to the public, and is seeking public comments on the meeting and its agenda.